在SARS-CoV-2中,主要蛋白酶分裂MAGED2,以对抗宿主抗病毒防御
Xiaohui Ju1, Ziqiao Wang2, Pengcheng Wang2
1School of Medicine, Tsinghua University , Beijing, China.
mBio
|July 13, 2023
概括
严重急性呼吸道综合征冠状病毒2 (SARS-CoV-2) 主蛋白酶 (Mpro) 切割宿主因子MAGED2,抑制其抗病毒活性. 这种保存的机制允许SARS-CoV-2克服宿主防御和复制.
科学领域:
- 病毒学 病毒学
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 严重急性呼吸道综合征冠状病毒2 (SARS-CoV-2) 使用蛋白酶进行复制,但对限制感染的宿主因素尚未完全理解.
- SARS-CoV-2编码主要蛋白质酶 (Mpro) 和类似帕帕因的蛋白质酶 (PLpro) 用于聚蛋白加工.
- 宿主-病原体相互作用对于病毒复制和病原体产生至关重要.
研究的目的:
- 研究SARS-CoV-2 Mpro与宿主因子之间的相互作用.
- 阐明MAGED2在SARS-CoV-2感染中的作用及其由Mpro.调节.
- 为了确定COVID-19的潜在治疗点.
主要方法:
- 在实验室中使用SARS-CoV-2 Mpro和人类MAGED2.2进行切割分析.
- 从不同SARS-CoV-2变种和其他冠状病毒 (SARS-CoV,MERS-CoV) 中Mpro对MAGED2裂变的分析.
- 在细胞培养中进行MAGED2枯竭和过度表达研究,以评估其对病毒复制的影响.
- 同免疫沉试验用于研究MAGED2,核囊蛋白和病毒RNA之间的相互作用.
主要成果:
- SARS-CoV-2 Mpro 在 Gln-263 中切割人类的 MAGED2,这是哺乳动物冠状病毒中保存的机制.
- 与野生型相比,来自Beta变异的Mpro在分裂MAGED2方面显示出更高的效率,而Omicron Mpro则显示出相反的情况.
- MAGED2通过破坏核囊蛋白和病毒基因组之间的RNA依赖相互作用来抑制SARS-CoV-2的复制.
- Mpro对MAGED2的裂变导致其N端片段的核转移,使其无法抑制病毒复制.
结论:
- MAGED2通过干扰病毒复制,作为对抗SARS-CoV-2的宿主抗病毒因子.
- SARS-CoV-2 Mpro通过分裂MAGED2来对抗这种宿主反应,从而促进病毒的传播.
- 通过Mpro变异的MAGED2的差异性裂变效率突出显示了不断变化的病毒策略.
- 了解这种病毒与宿主相互作用,可以了解针对SARS-CoV-2的新型治疗策略.
相关概念视频
The Antiviral System of Bacteria and Archaea: CRISPR
60
CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats is a adaptive immune system found in bacteria and archaea that protects against viral infections. This system enables prokaryotic cells to identify, remember, and neutralize foreign genetic elements, primarily bacteriophages, by storing fragments of the invader’s DNA as a genetic memory.The CRISPR immune response begins during an initial infection. Cas (CRISPR-associated) proteins play a central role in this...
60
Leaky Scanning
5.2K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.2K
Rous Sarcoma Virus (RSV) and Cancer
5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.1K
CRISPR and crRNAs
17.1K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.1K
Caspases
12.6K
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
12.6K
Immune Response Against Viral Pathogens
828
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
828


